Felix Ehret, Eilís Perez, Daniel Teichmann, Sandra Meier, Carola Geiler, Zeus Cosmas, Helene Franke, Siyer Roohani, David Wasilewksi, Julia Onken, Peter Vajkoczy, Leonille Schweizer, David Kaul, David Capper
The combination of DNA methylation analysis with histopathological and genetic features allows for a more accurate risk stratification and classification of meningiomas. Nevertheless, the implications of this classification for patients with grade 2 meningiomas, a particularly heterogeneous tumor entity, are only partially understood. We correlate the outcomes of histopathologically confirmed grade 2 meningioma with an integrated molecular-morphologic risk stratification and determine its clinical implications...
May 8, 2024: Acta Neuropathologica Communications